Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Wednesday, December 31, 2025
Advertising
About Us
Subscribe to Newsletter
Facebook
Twitter
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
LATEST ARTICLES
Pharma
Otsuka’s Sibeprenlimab Shows Strong Results in Phase 3 Trial for IgA Nephropathy
Life Sciences Times
-
June 6, 2025
0
Real Estate
Suffolk Unveils White Paper to Drive Climate Tech Adoption in Construction Industry
Life Sciences Times
-
June 6, 2025
0
Healthcare
Tracer Biotechnologies Partners with QIAGEN to Expand Blood-Based Cancer Testing
Life Sciences Times
-
June 6, 2025
0
Healthcare
MeMed Reaches 100,000-Patient Milestone for Rapid Infection Diagnostic Test
Life Sciences Times
-
June 6, 2025
0
Medtech
HistoSonics Completes Enrollment in Pivotal Trial Testing Non-Invasive Kidney Tumor Treatment
Life Sciences Times
-
June 6, 2025
0
People on the Move
Dr. Drew Kurtzman Joins AndHealth Dermatology, Now Seeing Patients in Ohio and Kentucky
Life Sciences Times
-
June 6, 2025
0
Biotech
IDEXX Launches In-Clinic Cortisol Test to Help Veterinarians Diagnose Canine Endocrine Disorders
Life Sciences Times
-
June 5, 2025
0
People on the Move
Charter Next Generation Names Lisa Alteri as Chief Operating Officer to Drive Operational Strategy and Growth
Life Sciences Times
-
June 5, 2025
0
Pharma
Mediar Therapeutics Begins Phase 2 Trial of MTX-463 for Idiopathic Pulmonary Fibrosis
Life Sciences Times
-
June 5, 2025
0
Public Health
Genetic Marker Linked to Immunotherapy Resistance in Deadly Skin Cancer, NYU Study Finds
Life Sciences Times
-
June 5, 2025
0
1
...
121
122
123
...
776
Page 122 of 776
Most Popular
Verastem Oncology Discontinues RAMP 203 Trial to Prioritize KRAS G12D Program
December 30, 2025
Vicarious Surgical Partners With Global Software Firm to Streamline Development Operations
December 30, 2025
Establishment Labs Submits Motiva Implants to FDA for Breast Reconstruction Approval
December 29, 2025
Johnson & Johnson Completes Acquisition of Halda Therapeutics
December 29, 2025
Load more
Recent Comments
Recent Comments